Search research articles
Contact Us
Filters
Showing results (261-270 of 305) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
It is time to include patients with brain tumors in phase I trials in oncology
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Neuro-Oncology
|
March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors
Stuart A Grossman, Amy Barone, Roy E Strowd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2006
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Timothy F Cloughesy, Patrick Y Wen, H Ian Robins, et al.
Journal of Neuro-Oncology
|
October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
Morris D Groves, Vinay K Puduvalli, Susan M Chang, et al.
Neuro-Oncology
|
December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813
Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growth
Collin J Dube, Ying Zhang, Shekhar Saha, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Neuro-Oncology
|
April 17, 2018
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Benjamin M Ellingson, Dana T Aftab, Gisela M Schwab, et al.
Neuro-Oncology
|
July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors
Anthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Page
of 31
Search research articles
Search
Showing results (261-270 of 305) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
It is time to include patients with brain tumors in phase I trials in oncology
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Neuro-Oncology
|
March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors
Stuart A Grossman, Amy Barone, Roy E Strowd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2006
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study
Timothy F Cloughesy, Patrick Y Wen, H Ian Robins, et al.
Journal of Neuro-Oncology
|
October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
Morris D Groves, Vinay K Puduvalli, Susan M Chang, et al.
Neuro-Oncology
|
December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813
Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growth
Collin J Dube, Ying Zhang, Shekhar Saha, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Neuro-Oncology
|
April 17, 2018
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Benjamin M Ellingson, Dana T Aftab, Gisela M Schwab, et al.
Neuro-Oncology
|
July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors
Anthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Page
of 31